Abstract
Human melanoma line MZ2-MEL expresses several antigens recognized by autologous cytolytic T lymphocytes (CTL). As a first step towards the cloning of the gene coding for one of these antigens, we tried to obtain transfectants expressing the antigen. The DNA recipient cell was a variant of MZ2-MEL which had been selected with a CTL clone for the loss of antigen E. It was cotransfected with genomic DNA of the original melanoma line and with selective plasmid pSVtkneoβ. Geneticin-resistant transfectants were obtained at a frequency of 2 × 10−4. These transfectants were then screened for their ability to stimulate the production of tumor necrosis factor by the anti-E CTL clone. One transfectant expressing antigen E was identified among 70 000 drug-resistant transfectants. Its sensitivity to lysis by the anti-E CTL was equal to that of the original melanoma cell line. When this transfectant was submitted to immunoselection with the anti-E CTL clone, the resulting antigen-loss variants were found to have lost several of the transfected pSVtkneoβ sequences. This indicated that the gene coding for the antigen had been integrated in the vicinity of pSVtkneoβ sequences, as expected for cotransfected DNA.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anichini, A., Fossati, G., and Parmiani, G.: Clonal analysis of the cytolytic T-cell response to human tumors. Immunol Today 8: 385–389, 1987
Boon, T., Van Snick, J., Van Pel, A., Uyttenhove, C., and Marchand, M.: Immunogenetic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis. J Exp Med 152: 1184–1193, 1980
Brunner, K., Macdonald, R., and Cerottini, J. C.: Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro. J Immunol 124: 1627–1634, 1980
Corsaro, C. M. and Pearson, M. L.: Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells. Somat Cell Mol Genet 7: 603–616, 1981
Degiovanni, G., Hainaut, P., Lahaye, T., Weynants, P., and Boon, T.: Antigens recognized on a melanoma cell line by autologous cytolytic T lymphocytes are also expressed on freshly collected tumor cells. Eur J Immunol 20: 1865–1868, 1990
Espevik, T. and Nissen-Meyer, J.: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95: 99–105, 1986
Hansen, M. B., Nielsen, S. E., and Berg, K.: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203–210, 1989
Hérin, M., Lemoine, C., Weynants, P., Vessière, F., Van Pel, A., Knuth, A., Devos, R., and Boon, T.: Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer 39: 390–396, 1987
Hoeijmakers, J. H. J., Odijk, H., and Westerveld, A.: Differences between rodent and human cell lines in the amount of integrated DNA after transfection. Exp Cell Res 169: 111–119, 1987
Kast, W. M., Offringa, R., Peters, P. J., Voordouw, A. C., Meloen, R. H., van der Eb A. J., and Melief, C. J. M.: Eradication of Adenovirus E1-induced tumors by E1A specific cytotoxic T lymphocytes. Cell 59: 603–614, 1989
Klein, G., Sjogren, H., Klein, E., and Hellström, K. E.: Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochtonous host. Cancer Res 20: 1561–1572, 1960
Knuth, A., Danowski, B., Oettgen, H. F., and Old, L.: T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin-2-dependent T-cell cultures. Proc Natl Acad Sci USA 81: 3511–3515, 1984
Knuth, A., Wölfel, T., Klehmann, E., Boon, T., Meyer zum Büschenfelde, K.-H.: Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci USA 86: 2804–2808, 1989
Kripke, M. L.: Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 53: 1333–1336, 1974
Levy, J. P. and Leclerc, J. C.: The murine-sarcoma-virus-induced tumor: exceptions or general model in tumor immunology. Adv Cancer Res 24: 1–59, 1977
Lurquin, C., Van Pel, A., Mariamé, B., De Plaen, E., Szikora, J.-P., Janssens, C., Reddehase, M. J., Lejeune, J., and Boon, T.: Structure of the gene coding for tum− transplantation antigen P91A. A peptide encoded by the mutated exon is recognized with Ld by cytolytic T cells. Cell 58: 293–303, 1989
Maryanski, J. L., Van Snick, J., Cerottini, J.-C., and Boon, T.: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. Eur J Immunol 12: 401–406, 1982
Mukherji, B. and MacAlister, T. J.: Clonal analysis of cytotoxic T-cell response against human melanoma. J Exp Med 158: 240–245, 1983
Nicolas, J. F. and Berg, P.: Regulation of expression of genes transduced into embryonal carcinoma cells. Cold Spring Harbor Conferences Cell Prolif 10: 469–485, 1983
Old, L. J., Boyse, E. A., Clarke, D. A., and Carswell, E. A.: Antigenic properties of chemically-induced tumors. Ann NY Acad Sci 10: 80–106, 1962
Perucho, M., Hanahan, D., and Wigler, M.: Genetic and physical linkage of exogenous sequences in transformed cells. Cell 22: 309–317, 1980
Prehn, R. T. and Main, J. M.: Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst 18: 769–778, 1957
Sibille, C. P., Chomez, C., Wildmann, A., Van Pel, E., De Plaen, J., Maryanski, J., de Bergeyck, V., and Boon, T.: Structure of the gene of tum− transplantation antigen P198: a point mutation generates a new antigenic peptide. J Exp Med 172: 35–45, 1990
Szikora, J. P., Van Pel, A., Brichard, V., André, M., Van Baren, N., Henry, P., De Plaen, E., and Boon, T.: Structure of the gene of tum− transplantation antigen P35B: presence of a point mutation in the antigenic allele. EMBO J 9: 1041–1050, 1990
Topalian, S. L., Solomon, D., Davis, F. P., Chan, A. E., Freerdsen, D. L., Linehan, W. M., Lotze, M. T., Robertson, C. N., Seipp, C. A., Simon, P., Simpson, C. G., and Rosenberg, S. A.: Immunotherapy of patients with advanced cancer using tumor-in-filtrating lymphocytes and recombinant interleukin-2: a pilot study. J Clin Oncol 6: 839–853, 1988
Topalian, S. L., Kasid, A., Rosenberg, S. A.: Immunoselection of a human melanoma resistant to specific lysis by autologous tumor-infiltrating lymphocytes. Possible mechanisms for Immunotherapeutic failures. J Immunol 144: 4487–4495, 1990
Uyttenhove, C., Maryanski, J., and Boon, T.: Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression. J Exp Med 157: 1040–1052, 1983
Van den Eynde, B., Hainaut, P., Hérin, M., Knuth, A., Lemoine, C., Weynants, P., van der Bruggen, P., Fauchet, R., and Boon, T.: Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 44: 634–640, 1989
Van den Eynde, B., Lethé, B., Van Pel, A., De Plaen, E., and Boon, T.: The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med 173: 1373–1384, 1991
Van Pel, A., Vessière, F., and Boon, T.: Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis. J Exp Med 157: 1992–2001, 1983
Wigler, M., Pellicer, A., Silverstein, S., and Axel, R.: Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell 14: 725–731, 1978
Wölfel, T., Van Pel, A., De Plaen, E., Lurquin, C., Maryanski, J. L., and Boon, T.: Immunogenetic (tum−) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum− antigen with a cytolytic T cell stimulation assay. Immunogenetics 26: 178–187, 1987
Wölfel, T., Klehmann, E., Müller, C., Schütt, K.-H., Meyer zum Büschenfelde, K.-H., and Knuth, A.: Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J Exp Med 170: 797–810, 1989
Author information
Authors and Affiliations
Additional information
Address correspondence and offprint requests to: T. Boon.
Rights and permissions
About this article
Cite this article
Traversari, C., van der Bruggen, P., Van den Eynde, B. et al. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics 35, 145–152 (1992). https://doi.org/10.1007/BF00185107
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00185107